South Cone Investments Limited Partnership, 10% Owner at Rani Therapeutics Holdings, Inc. (RANI), sold 7,658,720 shares at $2.55 ($20.3M) on 2024-10-15, disclosed to the SEC on 2024-10-17.
Open-market sale of $20.3M RANI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.55 | 3,305,622 | $8.4M | 41.6% |
| 2 | $2.55 | 3,305,622 | $8.4M | 41.6% |
| 3 | $3.26 | 523,738 | $1.7M | 8.4% |
| 4 | $3.26 | 523,738 | $1.7M | 8.4% |
| Total | $2.65 avg | 7,658,720 | $20.3M | 100% |
| Filing → |
| RANI | BUY | 2023-05-05 | $10K | — | Filing → |
| RANI | BUY | 2023-05-02 | $10K | — | Filing → |
| RANI | BUY | 2023-04-24 | $30K | — | Filing → |